CROSSROADS STRATEGIES, LLC

Lobbying for GINKGO BIOWORKS, INC. · biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Education and outreach on automated lab technology; FY2027 National Defense Authorization Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.